NCT01031199 Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01028209 Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions Status TERMINATED Phase PHASE1
NCT01024985 Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct Status UNKNOWN Phase N/A
NCT01024777 Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis Status COMPLETED Phase PHASE1
NCT01023074 Effects of Training on Central Auditory Function in Multiple Sclerosis Status COMPLETED Phase NA
NCT01020370 Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies Status COMPLETED Phase N/A
NCT01018485 The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor Status COMPLETED Phase PHASE3
NCT01013350 Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials Status COMPLETED Phase N/A
NCT01006265 Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01005095 The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients Status TERMINATED Phase PHASE4
NCT00997438 Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis Status COMPLETED Phase PHASE1
NCT00988988 The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections Status WITHDRAWN Phase PHASE4
NCT00986960 Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS) Status WITHDRAWN Phase PHASE2
NCT00981643 Effects of Meditation on Multiple Sclerosis and Peripheral Neuropathy Status COMPLETED Phase NA
NCT00981084 Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS) Status COMPLETED Phase PHASE2/PHASE3
NCT00972062 Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis Status COMPLETED Phase NA
NCT00970333 Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions Status COMPLETED Phase PHASE1